What is the equity of Zeria Pharmaceutical Co this year?
Zeria Pharmaceutical Co has equity of 79.62 B JPY this year.
Zeria Pharmaceutical Co Equity 2024
Zeria Pharmaceutical Co Equity
79.62 B JPY
Ticker
4559.T
ISIN
JP3428850006
In 2024, Zeria Pharmaceutical Co's equity was 79.62 B JPY, a 45.05% increase from the 54.89 B JPY equity in the previous year.
Zeria Pharmaceutical Co Aktienanalyse
What does Zeria Pharmaceutical Co do?
Zeria Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Zeria Pharmaceutical Co's Equity
Zeria Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Zeria Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Zeria Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Zeria Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Zeria Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Zeria Pharmaceutical Co stock
What was the equity of Zeria Pharmaceutical Co compared to the previous year?
The equity of Zeria Pharmaceutical Co has increased/decreased by 45.05% increased compared to the previous year.
What impact does a high equity have on investors of Zeria Pharmaceutical Co?
A high equity is advantageous for investors of Zeria Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Zeria Pharmaceutical Co?
A low equity can be a risk for investors of Zeria Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Zeria Pharmaceutical Co affect the company?
An increase in equity of Zeria Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Zeria Pharmaceutical Co affect the company?
A reduction in equity of Zeria Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Zeria Pharmaceutical Co?
Some factors that can affect the equity of Zeria Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Zeria Pharmaceutical Co so important for investors?
The equity of Zeria Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Zeria Pharmaceutical Co take to change the equity?
To change equity, Zeria Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Zeria Pharmaceutical Co pay?
Over the past 12 months, Zeria Pharmaceutical Co paid a dividend of 45 JPY . This corresponds to a dividend yield of about 2.15 %. For the coming 12 months, Zeria Pharmaceutical Co is expected to pay a dividend of 46.78 JPY.
What is the dividend yield of Zeria Pharmaceutical Co?
The current dividend yield of Zeria Pharmaceutical Co is 2.15 %.
When does Zeria Pharmaceutical Co pay dividends?
Zeria Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Zeria Pharmaceutical Co?
Zeria Pharmaceutical Co paid dividends every year for the past 23 years.
What is the dividend of Zeria Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 46.78 JPY are expected. This corresponds to a dividend yield of 2.24 %.
In which sector is Zeria Pharmaceutical Co located?
Zeria Pharmaceutical Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zeria Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zeria Pharmaceutical Co from 12/1/2024 amounting to 23 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Zeria Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Zeria Pharmaceutical Co in the year 2023?
In the year 2023, Zeria Pharmaceutical Co distributed 44 JPY as dividends.
In which currency does Zeria Pharmaceutical Co pay out the dividend?
The dividends of Zeria Pharmaceutical Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zeria Pharmaceutical Co
Our stock analysis for Zeria Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zeria Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Zeria Pharmaceutical Co Revenue
- Zeria Pharmaceutical Co Net Income
- Zeria Pharmaceutical Co P/E
- Zeria Pharmaceutical Co P/S
- Zeria Pharmaceutical Co EBIT
- Zeria Pharmaceutical Co Dividend
- Zeria Pharmaceutical Co Stocks
- Zeria Pharmaceutical Co Market capitalization
- Zeria Pharmaceutical Co Debt
- Zeria Pharmaceutical Co Liabilities
- Zeria Pharmaceutical Co Equity
- Zeria Pharmaceutical Co AAQS
- Zeria Pharmaceutical Co Employees
- Zeria Pharmaceutical Co ROE
- Zeria Pharmaceutical Co ROA
- Zeria Pharmaceutical Co ROCE